Effects of NGX6 gene on cell cycle in colon cancer cell line HT-29

Progress in Biochemistry and Biophysics

Volumn 33, Issue 1, 2006, Pages 45-50

  Wang, Xiao Yan ^a   Shen, Shou Rong ^a   Liu, Fen ^a   Li, Xiao Ling ^b   Fan, Song Qing ^b  

^a CENTRAL SOUTH UNIVERSITY   (China)

^b Central South University   (China)

Author keywords

Cell cycle; Cyclin dependent kinase inhibitor (CKI); Cyclins; HT 29 cell; NGX6 gene

Indexed keywords

EID: 33645764403     PISSN: 10003282     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (14)

1. Yang J B, Bin L H, Li Z H, et al. Refined localization and cloning of a novel putative tumor suppressor gene associated with nasopharyngeal carcinoma on chromosome 9p21-22. Clin J Cancer, 2000, 19 (1): 6-9
2. Wang L, Ma J, Li J, et al. NGX6 gene inhibits cell proliferation and plays a negative role in EGFR pathway in nasopharyngeal carcinoma cells. J Cell Biochem, 2005, 95: 64-73
3. Zhang X M, Shen S R, Wang X Y, et al. World Chin J Digest, 2002, 10 (8): 873-876
4. Wang X Y, Shen S R, Liu H Y, et al. World Chin J Digest, 2004, 12 (3): 574-579
5. Farley J, Smith L M, Darcy K M, et al. Cyclin E expression is a significant predictor of survival in advanced, suboptimally debulked ovarian epithelial cancers: a gynecologic oncology group study. Cancer Res, 2003, 63 (6): 1235-1241
6. Coradini D, Daidone M G. Biomolecular prognostic factors in breast cancer. Curr Opin Obstet Gynecol, 2004, 16 (1): 49-55
7. Liang B, Wang S, Yang X, et al. Expressions of cyclin E, cyclin dependent kinase 2 and p57(KIP2) in human gastric cancer. Chin Med J (Engl), 2003, 116 (1): 20-23
8. Schraml P, Bucher C, Bissig H, et al. Cyclin E overexpression and amplification in human tumours. J Pathol, 2003, 200 (3): 375-382
9. Ioachim E, Michael M, Stavropoulos N E, et al. Expression patterns of cyclins D1, E and cyclin-dependent kinase inhibitors p21 (Waf1/Cip1) and p27(Kip1) in urothelial carcinoma: correlation with other cell-cycle-related proteins (Rb, p53, Ki-67 and PCNA) and clinicopathological features. Urol Int, 2004, 73 (1): 65-73
10. Zhou Q, He Q, Liang L J. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance. World J Gastroenterol, 2003, 9 (11): 2450-2454
11. Gump J, Stokoe D, McCormick F. Phosphorylation of p16INK4A correlates with Cdk4 association. J Biol Chem, 2003, 278 (9): 6619-6622
12. Matsuda Y, Ichida T, Genda T. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma. Clin Cancer Res, 2003, 9 (9): 3389-3396
13. Xiao Y, Monitto C L, Minhas K M, et al. Lactoferrin down-regulates G1 cyclin-dependent kinases during growth arrest of head and neck cancer cells. Clin Cancer Res, 2004, 10 (24): 8683-8686
14. Marches R, Uhr J W. Enhancement of the p27Kip1-mediated antiproliferative effect of trastuzumab (Herceptin) on HER2-overexpressing tumor cells. Int J Cancer, 2004, 112 (3): 492-501